EFFECT OF ATHEROSCLEROSIS ON BONE TISSUE
Ключевые слова:
Key words: cardiovascular diseases, atherosclerosis, osteoporosis.Аннотация
Atherosclerosis and osteoporosis are not only age-related, but also have common pathogenetic mechanisms. Blood vessels and bone tissue have similar morphological characteristics, and vascular calcifications are composed of the same components as bone tissue. Modern medicine emphasizes the need to identify specific relationships between these diseases and their common pathogenetic mechanisms in order to develop a complex and individual approach to diagnosis, treatment and prevention.
Библиографические ссылки
1. Aganov D.S., Toporkov M.M., Svintsitskaya I.S. and others. Fracture as a predictor of decreased bone mass: pathogenetic aspects, possible methods of correction // Breast Cancer. Medical Review. – 2023. - No. 3. - P. 160-166.
2. Verbovoy A.F., Mitroshina E.V. Pashentseva A.V. The relationship between the pathogenesis of atherosclerosis and osteoporosis // Obesity and metabolism. -2016. No. 4. -WITH. 8-14
3. Maychuk E.Yu., Voevodina I.V., Makarova I.A. and others. The risk of developing atherosclerosis and osteoporosis in women with postovariectomy syndrome during hormone replacement therapy // Therapeutic archive - 2014. - No. 3. –P.75-79.
4. Menshikova L.V., Khramtsova N.A., Ershova O.B. and others. Short-term and long-term outcomes of fractures of the proximal femur in elderly people and their medical and social consequences (according to a multicenter study). //Osteoporosis and osteopathies. – 2002. -№1. –P.8 - 11.
5. Mitrokhina T.V., Yureneva S.V., Maychuk E.Yu. and others. The state of the cardiovascular system and bone mineral density in women after bilateral oophorectomy. //Problem women's health -2011. -No. 3. –S. 18-25.
6. Mikhailov E.E., Benevolenskaya L.I., Mylov R.M. Prevalence of vertebral fractures in a population sample of people 50 years of age and older. //Bulletin of traumatology and orthopedist named after. NOT. Priorova. – 1997. -№3. – P. 20 - 7.
7. A Guide to Osteoporosis edited by Prof. L.I. Benevolenskaya. BINOMIAL. Knowledge Laboratory. – 2003. –P.11-53.
8. Skripnikova I.A., Alikhanova N.A., Kolchina M.A., Myagkova M.A., Kosmatova O.V.//Atherosclerosis and osteoporosis. Common targets for cardiovascular and anti-osteoporosis drugs (Part I). The effect of cardiovascular drugs on bone tissue strength. – 2019. - No. 1. - P.69-76
9. Skripnikova I.A. The relationship between cardiovascular diseases caused by atherosclerosis and osteoporosis in postmenopausal women //Modern rheumatology. – 2008. - No. 1.- P.41-47.
10. Spirtus T.V., Mikhailov E.E., Benevolenskaya L.I. Mineral density of bone tissue of the lumbar spine and femoral neck in patients from an epidemiological sample of Moscow. //Clin rheumatol. – 1997. -№3. –P.31-37.
11. Baldini V., Mastropasqua M., Francucci C.M. et al. Cardiovascular disease and osteoporosis. //J.Endocrinol Invest. – 2005. -№10.- Vol.28. -P.69 - 72.
12. Cui R, Zhou L, Li Z, Li Q, Qi Z, Zhang J. Assessment risk of osteoporosis in Chinese people: relationship among body mass index, serum lipid profiles, blood glucose, and bone mineral density. //ClinInterv Aging. -2016 -№11.Jul 4. –P. 887-95. doi: 10.2147.
13. D’Amelio P., Isaia C., Isaja G: C. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. //J. Endocrinol. Invest. -2009; -№4. .- Vol.32. - P.6–9.
14. Demir P., Erdenen F., Aral H., Emre T., Kose S., Altunoglu E., Dolgun A., Inal B. B., Turkmen A.. Serum osteoprotegerin levels with cardiovascular risk factors in chronic kidney disease. //J. Clin. Lab. Anal. -2016: Article: doi. 10.1002.
15. Dobnig H., Hofbauer L. Osteoporosis and atherosclerosis: common pathway. //J. Clin. Endocrinol. -2009. -№3. - Vol.2 -P. 12 -16.
16. Fuster V. Global burden of cardiovascular disease. Time to implement feasible strategies and to monitor results. //J. Am. College Cardiol. -2014. -№5. - Vol.64 .-P. 520-522.
17. Kasagi S., Chen W. TGF-beta 1 on osteoimmunology and the bone compaunet cells. Cell Biosci. – 2013. -№4.-Vol.8. Article doi: 10.1186.
18. Kuroyanagi G., Otsuka T., Yamamoto N., et.al. Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.Int. //J. Mol. Sci. -2014. -№10.-Vol.15. -P. 17886 - 17900.
19. Labovsky V., Vallone V. B. F., Martinez L. M. et.al. Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derivated factor-1 and their receptors in epithelial metastatic breast cancer cell lines. //Cancer Cell Internat.- 2012. -№12.-Vol.29. doi:10.1186.
20. Lanzer P., Boehm M., Sorribas V. et.al. Medial vascular calcification revised: review and perspectives. //J.Eur. Heart. -2014. -Vol.163: P. 1515–1525.
21. Laroche M., Pouilles J.M., Ribot C. et al. Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. //Clinrheumatol. -1994. -№4.-Vol.13. –P. 611- 614.
22. Liu W., Zhang X. Receptor activator of nuclear factor-kB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissue (review). //Mol. Med. Rep. -2015. -№5.-Vol.11.-P. 3212–18.
23. Mody N., Tintut Y., Radcliff K. et al. Vascular calcification and its relation on bone calcification: possible underlying mechanisms. //J.NuclCardiol. - 2003. -№2.-Vol.10. - P.177- 183.
24. O’Rourke C., Shelton G., Hutcheson J. D. et.al. Calcification of vascular smooth muscle cells and imaging of aortic calcification and inflammation. //J. Vis. Exp. - 2016. -Vol.111: - P. e. 54017.
25. Parhami F., Mody N., Gharavi N. et al. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. //J. Bone Miner Res. -2002. -№11.-Vol. 17. –P.1997–2003.
26. Pfister R., Mishels G., Sharp S.J. et al. Low bone mineral density predicts incidents heart failure in man and women: the EPIC (European Prospective Investigation Into Cancer and Nutrition) - Norfolk Prospective Study. JACC. //Heart failure. -2014.-№4.-Vol.2(4).-P.380-389. doi:10.1016/j.jchf.2014.03.010.
27. Puglisi MA, Cenciarelli C, Tesori V. et.al. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells. //J.Pathol. -2015.-№4.-Vol.236. -P. 479 - 490. doi: 10.1002.
28. Ribot C, Tremollieres F, Pouilles JM. Estrogènesetmodulateursspécifiques des récepteursestrogéniquesdans le traitement de l'ostéoporose [Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis]. //Ann Med Interne (Paris). -2000. -№6.-Vol.151. -P.490 - 496. French. PMID: 11104929.
29. Riggs B.L., Wahner H.W., Dunn W.L. et.al. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. //J.Clin Invest. -1981. -№2.-Vol.67. –P.328-335. doi: 10.1172.
30. Salvemini D, Manning P.T., Zweifel B.S. et.al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. //J.Clin Invest. -1995. -№1.-Vol.96. -P.301-318. doi: 10.1172.
31. Schulz E., Arfai K., Liu X., et al. Aortic Calcification and the Risk of Osteoporosis and Fractures. //J.ClinEndocrMetab. - 2004. -№9.-Vol.89 -P.4246-4253. doi: 10.1210/jc.2003-030964.
32. Seeley D.G., Browner W.S. et al. Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. //Ann Intern Med. – 1991. -№11.-Vol.115 –P.837-842.
33. Song S. O., Park K.W., Yoo S. et.all. Association of coronary artery disease and osteoporotic vertebral fracture in Korean men and women. //Endocrinol. Metab. -2012. -№1.-Vol. 27. -P. 39 - 44.
34. Van Compenhout A., Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. //Atherosclerosis.-2009. -№2.-Vol.204. - P. 321- 329.
35. Weitzmann N. M. The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. //Scientifica. – 2013. Article ID 125705, 29 p.
